| scholarly article | Q13442814 |
| P2093 | author name string | Steve Goodison | |
| Virginia Urquidi | |||
| Yijun Sun | |||
| P2860 | cites work | Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 |
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| Molecular classification of cancer: class discovery and class prediction by gene expression monitoring | Q27861072 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Repeated observation of breast tumor subtypes in independent gene expression data sets | Q28131820 | ||
| Clinical application of the 70-gene profile: the MINDACT trial | Q28267891 | ||
| Derivation of molecular signatures for breast cancer recurrence prediction using a two-way validation approach | Q28748329 | ||
| Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer | Q29615523 | ||
| Delineation of prognostic biomarkers in prostate cancer | Q29617971 | ||
| Breast cancer metastasis: markers and models | Q29618061 | ||
| A statistical perspective on gene expression data analysis | Q30761979 | ||
| Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks. | Q31050064 | ||
| The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. | Q31140694 | ||
| Microarray data analysis: from disarray to consolidation and consensus | Q33230059 | ||
| Pathway-BasedFeature Selection Algorithm for Cancer Microarray Data | Q33537191 | ||
| Local-learning-based feature selection for high-dimensional data analysis | Q33633714 | ||
| Nonlinear dimensionality reduction by locally linear embedding | Q33928873 | ||
| National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. | Q34299708 | ||
| Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes | Q34375924 | ||
| Towards a novel classification of human malignancies based on gene expression patterns | Q34378411 | ||
| Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer | Q34563697 | ||
| Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer | Q34596148 | ||
| The cancer biomarker problem | Q34767213 | ||
| Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study. | Q35006280 | ||
| In silico dissection of cell-type-associated patterns of gene expression in prostate cancer | Q35735648 | ||
| Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy | Q35751889 | ||
| Breast cancer classification and prognosis based on gene expression profiles from a population-based study | Q35918291 | ||
| Optimizing molecular signatures for predicting prostate cancer recurrence | Q36182273 | ||
| Improved breast cancer prognosis through the combination of clinical and genetic markers | Q36201698 | ||
| Molecular classification and molecular forecasting of breast cancer: ready for clinical application? | Q36250255 | ||
| Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy | Q36439622 | ||
| Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures | Q36955113 | ||
| The wisdom of the commons: ensemble tree classifiers for prostate cancer prognosis | Q37090197 | ||
| Genomic approaches to outcome prediction in prostate cancer | Q37526789 | ||
| The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade | Q37635788 | ||
| Iterative RELIEF for feature weighting: algorithms, theories, and applications | Q39336884 | ||
| Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer | Q40813169 | ||
| Breast cancer molecular subtypes respond differently to preoperative chemotherapy | Q42482998 | ||
| Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling | Q43640323 | ||
| Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer | Q43708520 | ||
| Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series | Q44811326 | ||
| Microarray-based classification and clinical predictors: on combined classifiers and additional predictive value | Q45506394 | ||
| A comparative study of feature selection and multiclass classification methods for tissue classification based on gene expression | Q50915311 | ||
| The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type. | Q54456774 | ||
| The beginning of the end for microarrays? | Q55050129 | ||
| A problem of dimensionality: a simple example | Q56431346 | ||
| Gene Selection for Cancer Classification using Support Vector Machines | Q56535529 | ||
| Wrappers for feature subset selection | Q56689295 | ||
| Iterative RELIEF for feature weighting | Q56689297 | ||
| Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease | Q57908314 | ||
| Molecular Forecasting of Breast Cancer: Time to Move Forward With Clinical Testing | Q59567719 | ||
| Gene expression correlates of clinical prostate cancer behavior | Q60156349 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neoplastic gene expression regulation | Q66660300 |
| P304 | page(s) | 855-862 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Bioanalysis | Q18616741 |
| P1476 | title | Derivation of cancer diagnostic and prognostic signatures from gene expression data | |
| Derivation of Cancer Diagnostic and Prognostic Signatures from Gene Expression Data | |||
| P478 | volume | 2 |
| Q36509712 | A Candidate Molecular Biomarker Panel for the Detection of Bladder Cancer |
| Q34334159 | Cancer progression modeling using static sample data |
| Q37511632 | Epigenetic silencing of ARRDC3 expression in basal-like breast cancer cells |
| Q51701169 | Genetic testing for metastasis: potential for improved cancer treatment |
| Q35760911 | How can grafted breast cancer models be optimized? |
| Q28727592 | Identification of Factors Contributing to Variability in a Blood-Based Gene Expression Test |
| Q49830802 | Identification of novel prognosis-related genes associated with cancer using integrative network analysis. |
| Q57811412 | Predicting Tumor Sensitivity to Chemotherapeutic Drugs in Oral Squamous Cell Carcinoma Patients |
| Q38632574 | Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization |
Search more.